Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

LILRB2 Protein (AA 22-461) (Fc Tag,AVI tag,Biotin)

LILRB2 Origine: Humain Hôte: HEK-293 Cells Recombinant >90 % as determined by SDS-PAGE. Active
N° du produit ABIN3137681
  • Antigène Voir toutes LILRB2 Protéines
    LILRB2 (Leukocyte Immunoglobulin-Like Receptor, Subfamily B (With TM and ITIM Domains), Member 2 (LILRB2))
    Type de proteíne
    Recombinant
    Activité biologique
    Active
    Attributs du protein
    AA 22-461
    Origine
    • 19
    • 2
    Humain
    Source
    • 14
    • 3
    • 2
    • 1
    • 1
    HEK-293 Cells
    Purification/Conjugué
    Cette LILRB2 protéine est marqué à la Fc Tag,AVI tag,Biotin.
    Séquence
    AA 22-461
    Specificité
    Biotinylation of this product is performed using Avitag™ technology. Briefly, the single lysine residue in the Avitag is enzymatically labeled with biotin.
    Attributs du produit
    High Quality Authentic Human LILRB2 Protein
    • The production of this recombinant, biotinylated LILRB2 protein is carried out using a proprietary expression platform.
    • As expression hosts, the human HEK293 cells have a variety of advantages compared to other cell types.
    • Most importantly, the proteins retain their authentic post-translational processing, which often translates into high bioactivity and stability.
    High Bioactivity & Detection Sensitivity
    • The bioactivity of biotinylated proteins is determined both by the structure of the protein itself, and by the way how biotinylation is performed.
    • For every single protein, multiple options of tags and biotinylation methods are tested and the products are evaluated in a variety of binding assays.
    • Only those with the best performance are selected for production.
    Low Batch-to-Batch Variation
    • Products are routinely tested using rigorous quality control measures to ensure consistent performance.
    • Newly produced products are subjected to side-by-side comparison with our internal standard in a variety of assays.
    • Only those within an acceptable margin of difference are allowed to be released.
    Pureté
    >90 % as determined by SDS-PAGE.
    niveau d'endotoxine
    Less than 1.0 EU per μg by the LAL method.
    Top Product
    Discover our top product LILRB2 Protéine
  • Commentaires

    Ready-to-use AvitagTM biotinylated protein:
    The product is exclusively produced using the AvitagTM technology. Briefly, a unique 15 amino acid peptide, the Avi tag, is introduced into the recombinant protein during expression vector construction. The single lysine residue in the Avi tag is enzymatically biotinylated by the E. Coli biotin ligase BirA.

    This single-point enzymatic labeling technique brings many advantages for commonly used binding assays. The biotinylation happens on the lysine residue of Avi tag, and therefore does NOT interfere with the target protein's natural binding activities. In addition, when immobilized on an avidin-coated surface, the protein orientation is uniform because the position of the Avi tag in the protein is precisely controlled.

    Restrictions
    For Research Use only
  • Format
    Lyophilized
    Buffer
    Tris with Glycine, Arginine and NaCl,  pH 7.5
    Conseil sur la manipulation
    Please avoid repeated freeze-thaw cycles.
    Stock
    -20 °C
  • Antigène
    LILRB2 (Leukocyte Immunoglobulin-Like Receptor, Subfamily B (With TM and ITIM Domains), Member 2 (LILRB2))
    Autre désignation
    LILRB2 (LILRB2 Produits)
    Synonymes
    CD85D Protein, ILT-4 Protein, ILT4 Protein, LIR-2 Protein, LIR2 Protein, MIR-10 Protein, MIR10 Protein, leukocyte immunoglobulin-like receptor subfamily A member 3 Protein, leukocyte immunoglobulin like receptor B2 Protein, LOC100433990 Protein, LILRB2 Protein
    Sujet
    Leukocyte immunoglobulin-like receptor subfamily B member 2 (LILRB2) is also known as CD85 antigen-like family member D (CD85d), Immunoglobulin-like transcript 4 (ILT-4), Monocyte / macrophage immunoglobulin-like receptor 10 (MIR-10), which is a member of the the subfamily B class of LIR receptors. LILRB2 is receptor for class I MHC antigens. LILRB2 recognizes a broad spectrum of HLA-A, HLA-B, HLA-C and HLA-G alleles. LILRB2 competes with CD8A for binding to class I MHC antigens. LILRB2 / CD85d inhibits FCGR1A-mediated phosphorylation of cellular proteins and mobilization of intracellular calcium ions.
    Poids moléculaire
    76.2 kDa
    Pathways
    Cellular Response to Molecule of Bacterial Origin
Vous êtes ici:
Support technique